Growth Metrics

Valion Bio (TIVC) Cash from Investing Activities (2022 - 2025)

Valion Bio has reported Cash from Investing Activities over the past 3 years, most recently at -$149000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$149000.0; the TTM value through Dec 2025 reached -$705000.0, down 2837.5%, while the annual FY2025 figure was -$705000.0, N/A changed from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$149000.0 at Valion Bio, down from -$10000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$5000.0 in Q3 2022 and troughed at -$526000.0 in Q1 2025.
  • A 3-year average of -$104250.0 and a median of -$22000.0 in 2023 define the central range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 1466.67% in 2023 and fell as far as 1466.67% in 2023.
  • Year by year, Cash from Investing Activities stood at -$5000.0 in 2022, then tumbled by 380.0% to -$24000.0 in 2023, then crashed by 520.83% to -$149000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for TIVC at -$149000.0 in Q4 2025, -$10000.0 in Q3 2025, and -$20000.0 in Q2 2025.